Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
INCOG BioPharma to Invest US$200 Million to Expand Injectable Manufacturing Capacity in Indiana
INCOG BioPharma has announced plans to invest approximately US$200 million in expanding its injectable drug product manufacturing facility in Indiana, USA The expansion will increase capacity for injectable drug product manufacturing at the Indiana site The facilities will include additional space
Sharp Services to Invest US$23.3 million (€20 Million) to Expand Injectables Packaging Capacity in Europe
Sharp Services is investing over US$233 million 20 Million to expand injectables packaging capacity at its European facilities in HamontAchel, Belgium, and Heerenveen, The Netherlands
AstraZeneca to Invest US$2 Billion to Expand Biologics and Clinical Manufacturing in Maryland
AstraZeneca has announced plans to invest US$2 billion in expanding its biologics and clinical manufacturing facilities in Maryland, USA
Lilly to Invest US$6.5 Billion to Build State-of-the-Art Active Pharmaceutical Ingredient Manufacturing Facility in Texas
Eli Lilly and Company has announced plans to invest US$65 billion to build a new stateoftheart manufacturing facility at Generation Park in Houston, Texas, USA
AstraZeneca to Invest US$4.5 Billion to Expand Manufacturing Facility in Virginia
AstraZeneca has announced plans to invest US$45 billion to expand its manufacturing facility at Rivanna Futures in Albemarle County, Virginia
Amgen to Invest US$650 Million to Expand Manufacturing Operations in the United States
Amgen has announced plans to invest US$650 million to expand its manufacturing operations in the United States
Axplora Expands Farmabios with US$38 Million (€35 Million) Site Development in Italy
Axplora is allocating US$38 million 35 million to expand its Farmabios site in Italy, doubling the footprint of the facility
AbbVie Invests US$195 Million to Expand API Manufacturing in USA
AbbVie plans to invest US$195 million to expand active pharmaceutical ingredient API manufacturing at its North Chicago facility in the United States
AstraZeneca Invests US$50 Billion to Expand Drug Manufacturing and R&D in USA
AstraZeneca plans to invest US$50 billion to expand its drug manufacturing and research and development operations across the United States
Veranova Invests US$50 Million to Expand ADC Manufacturing Facility in Massachusetts, USA
Veranova plans to invest over US$50 million to expand its manufacturing facility in Devens, Massachusetts, USA
